The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 21,384 | 439,900 | SH | SOLE | 439,900 | 0 | 0 | ||
ABBOTT LABS | COM | 002824100 | 525 | 10,800 | SH | DFND | 1 | 0 | 10,800 | 0 | |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 119 | 26,000 | SH | DFND | 1 | 0 | 26,000 | 0 | |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 4,847 | 1,056,100 | SH | SOLE | 1,056,100 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 494 | 9,400 | SH | DFND | 1 | 0 | 9,400 | 0 | |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 20,074 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 152 | 13,300 | SH | DFND | 1 | 0 | 13,300 | 0 | |
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 6,234 | 544,470 | SH | SOLE | 544,470 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 658 | 3,500 | SH | DFND | 1 | 0 | 3,500 | 0 | |
ANTHEM INC | COM | 036752103 | 26,498 | 140,850 | SH | SOLE | 140,850 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 138 | 9,868 | SH | DFND | 1 | 0 | 9,868 | 0 | |
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 5,612 | 402,277 | SH | SOLE | 402,277 | 0 | 0 | ||
CORIUM INTL INC | COM | 21887L107 | 5,852 | 784,508 | SH | SOLE | 784,508 | 0 | 0 | ||
CORIUM INTL INC | COM | 21887L107 | 144 | 19,258 | SH | DFND | 1 | 0 | 19,258 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 443 | 5,500 | SH | DFND | 1 | 0 | 5,500 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 17,790 | 221,100 | SH | SOLE | 221,100 | 0 | 0 | ||
DAVITA INC | COM | 23918K108 | 402 | 6,200 | SH | DFND | 1 | 0 | 6,200 | 0 | |
DAVITA INC | COM | 23918K108 | 16,358 | 252,600 | SH | SOLE | 252,600 | 0 | 0 | ||
EXPRESS SCRIPTS HLDG CO | COM | 30219G108 | 977 | 15,300 | SH | DFND | 1 | 0 | 15,300 | 0 | |
EXPRESS SCRIPTS HLDG CO | COM | 30219G108 | 39,964 | 626,001 | SH | SOLE | 626,001 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 63 | 13,627 | SH | DFND | 1 | 0 | 13,627 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,578 | 555,570 | SH | SOLE | 555,570 | 0 | 0 | ||
FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 12,948 | 636,900 | SH | SOLE | 636,900 | 0 | 0 | ||
FORWARD PHARMA A/S | SPONSORED ADR | 34986J105 | 317 | 15,600 | SH | DFND | 1 | 0 | 15,600 | 0 | |
GILEAD SCIENCES INC | COM | 375558103 | 630 | 8,900 | SH | DFND | 1 | 0 | 8,900 | 0 | |
GILEAD SCIENCES INC | COM | 375558103 | 25,828 | 364,900 | SH | SOLE | 364,900 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 1,253 | 97,750 | SH | DFND | 1 | 0 | 97,750 | 0 | |
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 51,146 | 3,989,514 | SH | SOLE | 3,989,514 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 38 | 20,200 | SH | DFND | 1 | 0 | 20,200 | 0 | |
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 1,565 | 823,522 | SH | SOLE | 823,522 | 0 | 0 | ||
LIFEPOINT HEALTH INC | COM | 53219L109 | 215 | 3,200 | SH | DFND | 1 | 0 | 3,200 | 0 | |
LIFEPOINT HEALTH INC | COM | 53219L109 | 8,763 | 130,500 | SH | SOLE | 130,500 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 33,356 | 405,300 | SH | SOLE | 405,300 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 815 | 9,900 | SH | DFND | 1 | 0 | 9,900 | 0 | |
MYLAN N V | SHS EURO | N59465109 | 839 | 21,600 | SH | DFND | 1 | 0 | 21,600 | 0 | |
MYLAN N V | SHS EURO | N59465109 | 34,375 | 885,500 | SH | SOLE | 885,500 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 828 | 18,000 | SH | DFND | 1 | 0 | 18,000 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 33,635 | 731,200 | SH | SOLE | 731,200 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 257 | 8,600 | SH | DFND | 1 | 0 | 8,600 | 0 | |
NEURODERM LTD | ORD SHS | M74231107 | 10,429 | 348,800 | SH | SOLE | 348,800 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 74 | 6,500 | SH | DFND | 1 | 0 | 6,500 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,020 | 267,000 | SH | SOLE | 267,000 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 114 | 5,900 | SH | DFND | 1 | 0 | 5,900 | 0 | |
RETROPHIN INC | COM | 761299106 | 4,661 | 240,389 | SH | SOLE | 240,389 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 9,509 | 946,200 | SH | SOLE | 946,200 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 232 | 23,100 | SH | DFND | 1 | 0 | 23,100 | 0 |